389 related articles for article (PubMed ID: 15124203)
1. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery.
Kerns EH; Di L; Petusky S; Farris M; Ley R; Jupp P
J Pharm Sci; 2004 Jun; 93(6):1440-53. PubMed ID: 15124203
[TBL] [Abstract][Full Text] [Related]
2. Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates.
Masungi C; Mensch J; Van Dijck A; Borremans C; Willems B; Mackie C; Noppe M; Brewster ME
Pharmazie; 2008 Mar; 63(3):194-9. PubMed ID: 18444507
[TBL] [Abstract][Full Text] [Related]
3. Transport mechanisms of flavanone aglycones across Caco-2 cell monolayers and artificial PAMPA membranes.
Kobayashi S; Nagai T; Konishi Y; Tanabe S; Morimoto K; Ogihara T
J Pharm Pharmacol; 2012 Jan; 64(1):52-60. PubMed ID: 22150672
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
[TBL] [Abstract][Full Text] [Related]
5. The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability.
Tam KY; Avdeef A; Tsinman O; Sun N
J Med Chem; 2010 Jan; 53(1):392-401. PubMed ID: 19947605
[TBL] [Abstract][Full Text] [Related]
6. QSAR study on permeability of hydrophobic compounds with artificial membranes.
Fujikawa M; Nakao K; Shimizu R; Akamatsu M
Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
[TBL] [Abstract][Full Text] [Related]
7. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
Akamatsu M; Fujikawa M; Nakao K; Shimizu R
Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
[TBL] [Abstract][Full Text] [Related]
8. Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method.
Avdeef A; Artursson P; Neuhoff S; Lazorova L; Gråsjö J; Tavelin S
Eur J Pharm Sci; 2005 Mar; 24(4):333-49. PubMed ID: 15734300
[TBL] [Abstract][Full Text] [Related]
9. Transport evaluation of salicylic acid and structurally related compounds across Caco-2 cell monolayers and artificial PAMPA membranes.
Koljonen M; Rousu K; Cierny J; Kaukonen AM; Hirvonen J
Eur J Pharm Biopharm; 2008 Oct; 70(2):531-8. PubMed ID: 18582575
[TBL] [Abstract][Full Text] [Related]
10. Permeation prediction of M100240 using the parallel artificial membrane permeability assay.
Hwang KK; Martin NE; Jiang L; Zhu C
J Pharm Pharm Sci; 2003; 6(3):315-20. PubMed ID: 14738711
[TBL] [Abstract][Full Text] [Related]
11. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability.
Fujikawa M; Ano R; Nakao K; Shimizu R; Akamatsu M
Bioorg Med Chem; 2005 Aug; 13(15):4721-32. PubMed ID: 15936203
[TBL] [Abstract][Full Text] [Related]
12. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of physicochemical properties and intestinal permeability of six dietary polyphenols in human intestinal colon adenocarcinoma Caco-2 cells.
Rastogi H; Jana S
Eur J Drug Metab Pharmacokinet; 2016 Feb; 41(1):33-43. PubMed ID: 25351179
[TBL] [Abstract][Full Text] [Related]
14. Contribution of the paracellular route to the pH-dependent epithelial permeability to cationic drugs.
Nagahara N; Tavelin S; Artursson P
J Pharm Sci; 2004 Dec; 93(12):2972-84. PubMed ID: 15459946
[TBL] [Abstract][Full Text] [Related]
15. Development of Cassette PAMPA for Permeability Screening.
Oh MH; Lee HJ; Jo SH; Park BB; Park SB; Kim EY; Zhou Y; Jeon YH; Lee K
Biol Pharm Bull; 2017; 40(4):419-424. PubMed ID: 28381797
[TBL] [Abstract][Full Text] [Related]
16. PAMPA--critical factors for better predictions of absorption.
Avdeef A; Bendels S; Di L; Faller B; Kansy M; Sugano K; Yamauchi Y
J Pharm Sci; 2007 Nov; 96(11):2893-909. PubMed ID: 17803196
[TBL] [Abstract][Full Text] [Related]
17. Relationships between structure and high-throughput screening permeability of peptide derivatives and related compounds with artificial membranes: application to prediction of Caco-2 cell permeability.
Ano R; Kimura Y; Shima M; Matsuno R; Ueno T; Akamatsu M
Bioorg Med Chem; 2004 Jan; 12(1):257-64. PubMed ID: 14697791
[TBL] [Abstract][Full Text] [Related]
18. A new in vitro system for evaluation of passive intestinal drug absorption: establishment of a double artificial membrane permeation assay.
Kataoka M; Tsuneishi S; Maeda Y; Masaoka Y; Sakuma S; Yamashita S
Eur J Pharm Biopharm; 2014 Nov; 88(3):840-6. PubMed ID: 25304077
[TBL] [Abstract][Full Text] [Related]
19. PAMPA--a drug absorption in vitro model 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones.
Bermejo M; Avdeef A; Ruiz A; Nalda R; Ruell JA; Tsinman O; González I; Fernández C; Sánchez G; Garrigues TM; Merino V
Eur J Pharm Sci; 2004 Mar; 21(4):429-41. PubMed ID: 14998573
[TBL] [Abstract][Full Text] [Related]
20. Comparison of blood-brain barrier permeability assays: in situ brain perfusion, MDR1-MDCKII and PAMPA-BBB.
Di L; Kerns EH; Bezar IF; Petusky SL; Huang Y
J Pharm Sci; 2009 Jun; 98(6):1980-91. PubMed ID: 18837012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
